Dermatopathology of Cutaneous Lymphomas
Cutaneous lymphomas are a diverse group of lymphoproliferative disorders primarily affecting the skin. Understanding their dermatopathology is critical for accurate diagnosis and effective management, given their varied presentations and potential for systemic involvement.
Topics: pathology, lymphoma, immunophenotyping
Overview / DefinitionCutaneous lymphomas are a heterogeneous group of malignancies arising from lymphocytes that primarily manifest in the skin. They can be classified into two main categories: primary cutaneous lymphomas, which originate in the skin, and secondary cutaneous lymphomas, which are disseminated from systemic lymphomas.EpidemiologyCutaneous lymphomas account for approximately 5-10% of all non-Hodgkin lymphomas, with their incidence varying significantly by subtype.Most common types include mycosis fungoides and Sezary syndrome.Mycosis fungoides generally presents in adults aged 50-60 years.Incidence is higher in males compared to females.Pathophysiology / MechanismThe pathogenesis of cutaneous lymphomas involves a complex interplay of genetic mutations, immunological factors, and environmental influences. The most common genetic alteration seen in mycosis fungoides is the t(14;18) chromosomal translocation.Environmental triggers may include chronic inflammation, infections, and exposure to certain chemicals.Immune dysregulation plays a crucial role in tumor development and progression.Clinical PresentationPatients with cutaneous lymphomas may present with a variety of skin manifestations, from patchy and plaque-like lesions to more aggressive tumors.Mycosis fungoides typically presents as erythematous patches or plaques, often resembling eczema or psoriasis.Advanced stages may display tumor nodules and ulceration.Sezary syndrome is characterized by erythroderma, lymphadenopathy, and circulating neoplastic T-cells.Diagnosis / WorkupThe diagnosis of cutaneous lymphomas requires a combination of clinical evaluation, histopathological examination, and sometimes additional laboratory investigations.Skin biopsy is essential for histological confirmation and should include at least part of the dermis.Immunohistochemistry is used to identify surface markers (e.g., CD4, CD8) that differentiate between lymphocyte subtypes.Pleomorphic variants may require addition